Literature DB >> 18304778

A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence.

Colin A Forestal1, Horacio Gil, Michael Monfett, Courtney E Noah, Gabrielle J Platz, David G Thanassi, Jorge L Benach, Martha B Furie.   

Abstract

Francisella tularensis is a highly virulent bacterium that causes tularemia, a disease that is often fatal if untreated. A live vaccine strain (LVS) of this bacterium is attenuated for virulence in humans but produces lethal disease in mice. F. tularensis has been classified as a Category A agent of bioterrorism. Despite this categorization, little is known about the components of the organism that are responsible for causing disease in its hosts. Here, we report the deletion of a well-characterized lipoprotein of F. tularensis, designated LpnA (also known as Tul4), in the LVS. An LpnA deletion mutant was comparable to the wild-type strain in its ability to grow intracellularly and cause lethal disease in mice. Additionally, mice inoculated with a sublethal dose of the mutant strain were afforded the same protection against a subsequent lethal challenge with the LVS as were mice initially administered a sublethal dose of the wild-type bacterium. The LpnA-deficient strain showed an equivalent ability to promote secretion of chemokines by human monocyte-derived macrophages as its wild-type counterpart. However, recombinant LpnA potently stimulated primary cultures of human macrophages in a Toll-like receptor 2-dependent manner. Although human endothelial cells were also activated by recombinant LpnA, their response was relatively modest. LpnA is clearly unnecessary for multiple functions of the LVS, but its inflammatory capacity implicates it and other Francisella lipoproteins as potentially important to the pathogenesis of tularemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304778      PMCID: PMC2483246          DOI: 10.1016/j.micpath.2008.01.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  58 in total

Review 1.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

2.  Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein.

Authors:  I Golovliov; M Ericsson; G Sandström; A Tärnvik; A Sjöstedt
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium.

Authors:  A Sjöstedt; G Sandström; A Tärnvik
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins.

Authors:  P Ancuta; T Pedron; R Girard; G Sandström; R Chaby
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro.

Authors:  T J Sellati; L D Abrescia; J D Radolf; M B Furie
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro.

Authors:  T J Sellati; M J Burns; M A Ficazzola; M B Furie
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification.

Authors:  J J Weis; Y Ma; L F Erdile
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

8.  Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia.

Authors:  M Fulop; R Manchee; R Titball
Journal:  Vaccine       Date:  1995-09       Impact factor: 3.641

9.  Growth of Francisella spp. in rodent macrophages.

Authors:  L D Anthony; R D Burke; F E Nano
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Cytokine expression in the liver during the early phase of murine tularemia.

Authors:  I Golovliov; G Sandström; M Ericsson; A Sjöstedt; A Tärnvik
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more
  17 in total

1.  Large scale structural rearrangement of a serine hydrolase from Francisella tularensis facilitates catalysis.

Authors:  Ekaterina V Filippova; Leigh A Weston; Misty L Kuhn; Brett Geissler; Alexandra M Gehring; Nicola Armoush; Chinessa T Adkins; George Minasov; Ievgeniia Dubrovska; Ludmilla Shuvalova; James R Winsor; Luke D Lavis; Karla J F Satchell; Daniel P Becker; Wayne F Anderson; R Jeremy Johnson
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

2.  Identification of disulfide bond isomerase substrates reveals bacterial virulence factors.

Authors:  Guoping Ren; Matthew M Champion; Jason F Huntley
Journal:  Mol Microbiol       Date:  2014-10-20       Impact factor: 3.501

3.  A tolC mutant of Francisella tularensis is hypercytotoxic compared to the wild type and elicits increased proinflammatory responses from host cells.

Authors:  Gabrielle J Platz; DeAnna C Bublitz; Patricio Mena; Jorge L Benach; Martha B Furie; David G Thanassi
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

4.  Interferon-γ influences the composition of leukocytic infiltrates in murine lyme carditis.

Authors:  Gregory J Sabino; Sonya J Hwang; Shane C McAllister; Patricio Mena; Martha B Furie
Journal:  Am J Pathol       Date:  2011-08-05       Impact factor: 4.307

Review 5.  Subversion of host recognition and defense systems by Francisella spp.

Authors:  Crystal L Jones; Brooke A Napier; Timothy R Sampson; Anna C Llewellyn; Max R Schroeder; David S Weiss
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

6.  GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages.

Authors:  Courtney E Noah; Meenakshi Malik; DeAnna C Bublitz; Devin Camenares; Timothy J Sellati; Jorge L Benach; Martha B Furie
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

7.  Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Authors:  Anne G Savitt; Patricio Mena-Taboada; Gloria Monsalve; Jorge L Benach
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

Review 8.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

9.  Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells.

Authors:  Matthew Hatkoff; Lisa M Runco; Celine Pujol; Indralatha Jayatilaka; Martha B Furie; James B Bliska; David G Thanassi
Journal:  Infect Immun       Date:  2012-07-30       Impact factor: 3.441

10.  TLR-dependent control of Francisella tularensis infection and host inflammatory responses.

Authors:  Allison L Abplanalp; Ian R Morris; Bijaya K Parida; Judy M Teale; Michael T Berton
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.